 Scrip Deals In a Feb. 6 warning letter to ExThera Medical Corporation, the Food and Drug Administration says the California-based device marketed its products without premarket authorization and failed to compl 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
